<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Tinos:ital,wght@0,400;0,700;1,400;1,700&display=swap"
        rel="stylesheet">

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Afacad+Flux:wght@100..1000&family=Tinos:ital,wght@0,400;0,700;1,400;1,700&display=swap"
        rel="stylesheet">

    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link
        href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,100;0,300;0,400;0,700;0,900;1,100;1,300;1,400;1,700;1,900&display=swap"
        rel="stylesheet">


    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Gemunu+Libre:wght@200..800&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="../css/nav.css">
    <link rel="stylesheet" href="../css/footer_2.css">
    <link rel="stylesheet" href="../css/about.css">

    <title> Oncology | Biointercept </title>

</head>

<body>
    <!-- <div class="alert">
        <p>
            <strong>Under Maintenance: Updating Webpages</strong>
        </p>
    </div> -->
    <div class="header">
        <div class="logo">
            <a href="../index.html"> <img src="../assets/cellara_logo_black.png" style="height: 8rem;" /> </a>
        </div>
        <div class="nav-links">
            <a href="../about.html" class="">WHO WE ARE</a>
            <a href="../research-areas" class="has-dropdown">RESEARCH AREAS</a>
            <a href="../technology-and-data.html" class="has-dropdown">TECHNOLOGY & DATA
                <!-- <span class="arrow-down"></span> -->
            </a>
            <a href="../resources.html">RESOURCES</a>
            <a href="../contact-us.html" class="contact-btn">CONTACT US</a>
            <a href="../investor.html">INVESTORS</a>
        </div>
    </div>


    <h1> Oncology & Hematology </h1>
    <h3 class="subtitle-h3"><span class="subtitle-h3-blue">

            Innovative </span> Oncological
        <span class="subtitle-h3-blue">

            Hematological </span> Treatment
        <span class="subtitle-h3-blue"> Expertise </span>

    </h3>


    <div class="hero-section">


        <div class="hero-image">
            <img src="./assets/oncology_page_pic.png" alt="Gene Illustration">
        </div>


        <div class="hero-content">



            <p>


Biointercept is at the forefront of oncology and hematology research, leveraging cutting-edge technologies to
revolutionize cancer treatment and blood disorder management. Our scientists employ advanced techniques with our proprietary exosome technology 
to help solve oncologies most challenging problems.
By integrating multi-omics data with sophisticated bioinformatics, we are uncovering
crucial insights into cancer progression, drug resistance mechanisms, and personalized treatment strategies, paving the
way for more effective and less toxic interventions.
<br />
Cancer remains a leading cause of death globally, with the oncology therapeutics market
exceeding $150 billion annually. Exosomes present a dual opportunity in oncology spanning
both therapeutic and diagnostic applications.
</p>



<h3 class="subtitle-h3" style="text-align: left; justify-content: left;"><span class="subtitle-h3-blue">
Therapeutic Applications
    </span>
</h3>


<p>


<ul style="justify-content: left; text-align:left; font-size:16px;">
    <li><span class="content-blue">Targeted Drug Delivery:</span>
    Exosomes can be engineered to deliver chemotherapeutic
    agents, small molecule inhibitors, or RNA-based therapies directly to tumor cells while
    sparing healthy tissues
 </li>
    <br />

    <li><span class="content-blue">Immunomodulation:</span>
Exosomes from dendritic cells or engineered with tumor antigens
can stimulate anti-tumor immune responses </li>
    <br />
    <li><span class="content-blue">Gene Therapy Delivery: </span>
Delivery of therapeutic mRNAs, siRNAs, or CRISPR-Cas9
components to cancer cells</li>
    <br />
    <li><span class="content-blue">Market Opportunity: </span>
        The total addressable market for our platform therapies is $280
        billion, with immediate addressable market of $220 billion in
        Regenerative Medicine across 6 critical need indications.</li>


</ul>

</p>

<h3 class="subtitle-h3" style="text-align: left; justify-content: left;"><span class="subtitle-h3-blue">
        Key Advantages
    </span>
</h3>
<p>

    This therapeutic platform demonstrates significantly enhanced penetration into solid tumors, outperforming
    conventional
    antibodies and nanoparticlses. Crucially, it possesses the unique ability to cross the blood-brain barrier, opening
    new
    avenues for effective brain tumor treatment. This precise targeting capability leads to substantially reduced
    off-target
    toxicity compared to conventional chemotherapy, improving patient safety. The platform's high degree of specificity
    is
    achieved by engineering exosome surface proteins. This versatility allows for multiple, simultaneous targeting
    strategies to be deployed. Ultimately, these combined attributes create a more potent and safer approach to treating
    historically challenging diseases.
</p>



<br /><br />

                <br /><br />
                Our talented team at <span class="content-blue"> Biointercept Biotechnology </span>
                delivers high quality services to ensure you meet your targeted results.
             
            </p>

            <h3 class="subtitle-h3">
                Reach out to us to
                <span class="subtitle-h3-blue"> learn more: </span>
            </h3>
            <a href="../contact-us.html" class="button">CONTACT US</a>
        </div>


    </div>
    <footer class="footer">
        <hr class="footer-divider">

        <div class="footer-content">
            <div class="footer-info">
                <p><strong>Biointercept Biotechnology Inc.</strong></p>

            </div>

            <div class="footer-links">
                <p>Â© 2025 Biointercept, All Rights Reserved |
                    <a href="../maintenance.html">Privacy Policy</a> |
                    <a href="../maintenance.html">Accessibility Statement</a> |

                    <a href="../maintenance.html">Terms of Use</a> |
                    <a href="../maintenance.html">Sitemap</a>
                </p>
            </div>

            <div class="social-icons">
                <a href="../maintenance.html" class="fa fa-facebook"></a>
                <a href="https://www.linkedin.com/company/Biointercept-biotech/" class="fa fa-linkedin"></a>

            </div>
        </div>
    </footer>


</body>

</html>